ACAT1 and cancer: In support of these reports, inhibition of CE/ACAT-1 either by avasimibe (data not shown) or by ACAT-1 specific shRNA, significantly reduced the migration, invasion and proliferation properties of the ACAT-1 inhibited cancer cell lines compared to their respective scrambled controls.